Browse

M&A overview: Overcoming COVID-19 and hope for the future

Despite the pandemic, an economic downturn and restrictions on both the general public and dealmakers, deal value in 2020 in CEE/SEE increased year-on-year. And our exclusive survey reveals growing levels of optimism for the year ahead

COVID-19 and CEE: How the pandemic will affect M&A in 2021

Our survey reveals that dealmakers are cautiously optimistic about post-pandemic prospects for M&A in the region with new opportunities emerging. But challenges still lie ahead

The great divide: Strategics vs sponsors in CEE

As and when the pandemic subsides, private equity and corporates will be in competition for the most prized assets in the region. But our survey reveals that their outlooks, attitudes and strategies are, at times, very different

Sector watch: The industries making waves in CEE dealmaking in 2021

While COVID-19 adversely affected almost all sectors in 2020, one industry not only survived but thrived. And, according to our survey, that sector is going to flourish again in 2021 and beyond

CEE healthcare M&A value rises in 2020 with more to come in 2021

The global pandemic, ageing populations and the burgeoning biotech subsector mean that the pharmaceuticals, medical and biotech (PMB) sector is set to see robust M&A activity in 2021

TMT M&A in CEE soars in 2020 and this year could be even better

Despite the pandemic, and, in some cases, because of it, M&A in the technology, media and telecommunications (TMT) sector has flourished. According to our survey, it will continue to do so